Godavari Drugs Complete Financial Statements
In FY2026, Godavari Drugs (GODAVARI) reported revenue ₹106 Cr, net profit ₹4 Cr and EPS ₹5.43, with a net profit margin of 3.8% and ROE of 5.6%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Godavari Drugs share price screener.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
GODAVARI Revenue, Net Profit & EBITDA — Year-on-Year Growth
GODAVARI YoY (March 2025 vs March 2026) — revenue -7.0%, EBITDA -23.1%, expenses -6.9%. Also explore Godavari Drugs stock price data download to track price trends across different timeframes.
GODAVARI Income Statement — Revenue, EBITDA & Net Profit
Godavari Drugs revenue ₹106 Cr, EBITDA ₹10 Cr, net profit ₹4 Cr, EPS ₹5.43 (2026) — net profit margin 3.8%. Analyse Godavari Drugs shareholding analysis to track promoter, FII and institutional holdings.
| Particulars | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 106 | 114 | 157 | 160 | 161 | 123 | 96 | 84 | 65 | 76 | 71 | 55 |
| Expenses | 95 | 102 | 143 | 150 | 150 | 113 | 90 | 78 | 60 | 70 | 67 | 49 |
| EBITDA | 10 | 13 | 14 | 11 | 12 | 10 | 6 | 6 | 5 | 6 | 5 | 6 |
| Operating Profit Margin % | 10.00% | 10.00% | 8.00% | 6.00% | 7.00% | 8.00% | 6.00% | 7.00% | 6.00% | 7.00% | 6.00% | 11.00% |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 4 | 5 | 5 | 4 | 3 | 3 | 3 | 3 | 2 | 3 | 2 | 1 |
| Profit Before Tax | 5 | 6 | 7 | 5 | 7 | 6 | 2 | 2 | 1 | 3 | 2 | 5 |
| Tax | 1 | 1 | 1 | 1 | 2 | 2 | 0 | 1 | 1 | 1 | 1 | 1 |
| Net Profit | 4 | 4 | 6 | 4 | 5 | 4 | 2 | 1 | 1 | 2 | 1 | 4 |
| Earnings Per Share (₹) | 5.43 | 5.82 | 7.37 | 5.03 | 6.97 | 5.48 | 2.66 | 1.60 | 1.10 | 2.40 | 1.79 | 4.84 |
GODAVARI Balance Sheet — Assets, Liabilities & Shareholders' Equity
GODAVARI total assets ₹200 Cr, total equity ₹71 Cr, total liabilities ₹ Cr (2026) — ROE 5.6%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 200 | 143 | 135 | 121 | 101 | 91 | 84 | 74 | 63 | 56 | 51 | 35 |
| Current Assets | 112 | 79 | 89 | 87 | 74 | 68 | 61 | 57 | 47 | 43 | 40 | 27 |
| Fixed Assets | 87 | 33 | 27 | 25 | 26 | 22 | 14 | 15 | 15 | 13 | 9 | 7 |
| Capital Work in Progress | 57 | 30 | 18 | 9 | 1 | 1 | 9 | 2 | 1 | 0 | 1 | 0 |
| Investments | 46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 81 | 90 | 87 | 75 | 68 | 61 | 57 | 48 | 43 | 41 | 27 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 40 | 27 | 14 | 14 | 14 | 16 | 12 | 9 | 9 | 6 | 5 | 5 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 71 | 43 | 39 | 33 | 30 | 24 | 20 | 18 | 17 | 16 | 14 | 13 |
| Share Capital | 10 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves & Surplus | 60 | 36 | 31 | 26 | 22 | 17 | 13 | 11 | 10 | 9 | 7 | 6 |
GODAVARI Cash Flow Statement — Operating, Investing & Financing
Godavari Drugs operating cash flow ₹11 Cr, investing ₹-20 Cr, financing ₹8 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 11 | 18 | 13 | 11 | 1 | 6 | 4 | 4 | 5 | -5 | -6 |
| Investing Activities | -20 | -13 | -9 | -5 | -1 | -7 | -2 | -3 | -3 | -2 | 0 |
| Financing Activities | 8 | -6 | -4 | -6 | 0 | 0 | -2 | 0 | -2 | 7 | 6 |
| Net Cash Flow | 0 | -1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |